 |
|
|
| |
Combination treatment of a TLR7 agonist RO7020531 and a core protein allosteric modulator RO7049389 achieved sustainable viral load suppression and HBsAgloss in an AAV-HBV mouse model
|
| |
| |
Reported by Jules Levin
EASL 2018 April 12 Paris France
Lue Dai1, YoujunYu1, XueZhou1, Lili Gu1, JieZhao1, Ying Ji1,HongyingYun1, Wei Zhu1, John A. T. Young2, and Lu Gao1
1Roche Innovation Centre Shanghai, Shanghai, China; 2. Roche Innovation Centre Basel, Basel, Switzerland
|
| |
|
|
|
|
|
